Regnum Corp
Regnum Corp. develops and commercializes therapeutics that treat rare and infectious diseases. It develops Leronlimab (PRO 140), a monoclonal antibody C"C chemokine receptor type 5 antagonist, that is designed to prevent human immunodeficiency virus from entering human cells. The company was incorporated in 2016 and is based in New York, New York.
Regnum Corp (RGMP) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of March 2023: 0.237x
Based on the latest financial reports, Regnum Corp (RGMP) has a cash flow conversion efficiency ratio of 0.237x as of March 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-320.50K) by net assets ($-1.35 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Regnum Corp - Cash Flow Conversion Efficiency Trend (2017–2022)
This chart illustrates how Regnum Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Regnum Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Regnum Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
VioQuest Pharmaceuticals Inc
PINK:VOQP
|
0.273x |
|
TANTALIZERS PLC
XNSA:TANTALIZER
|
N/A |
|
TRIPPLE GEE AND COMPANY PLC
XNSA:TRIPPLEG
|
N/A |
|
US Solar Fund PLC
LSE:USFP
|
-0.004x |
|
MUTUAL BENEFITS ASSURANCE PLC
XNSA:MBENEFIT
|
N/A |
|
REAL ESTATE INVESTMENTS ZAMBIA PLC
LUSE:REIZUSD
|
N/A |
|
Manila Bulletin Publishing Corp
PSE:MB
|
0.005x |
|
Hai Jia International Limited Company
PINK:HBIE
|
-4.559x |
Annual Cash Flow Conversion Efficiency for Regnum Corp (2017–2022)
The table below shows the annual cash flow conversion efficiency of Regnum Corp from 2017 to 2022.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-12-31 | $-1.16 Million | $-705.55K | 0.608x | +1893.60% |
| 2021-12-31 | $-379.82K | $-11.58K | 0.030x | -58.16% |
| 2020-12-31 | $-50.39K | $-3.67K | 0.073x | +101.44% |
| 2019-12-31 | $7.68K | $-38.85K | -5.059x | -5610.19% |
| 2018-12-31 | $44.06K | $4.04K | 0.092x | -62.19% |
| 2017-12-31 | $12.56K | $3.05K | 0.243x | -- |